• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CA-125在子宫内膜异位症诊断和管理中的应用。

The use of CA-125 in the diagnosis and management of endometriosis.

作者信息

Pittaway D E, Fayez J A

出版信息

Fertil Steril. 1986 Nov;46(5):790-5. doi: 10.1016/s0015-0282(16)49812-2.

DOI:10.1016/s0015-0282(16)49812-2
PMID:3465595
Abstract

CA-125, a cell-surface antigen, was measured by a radioimmunoassay in the serum of 414 women to determine its potential usefulness in the diagnosis and management of endometriosis. In women with minimal, mild, moderate, and severe endometriosis, the mean levels (+/- standard deviation) were 13.6 +/- 6.8, 22.8 +/- 15.5, 27 +/- 17, and 50 +/- 28 U/ml, respectively, and were significantly higher than mean levels (7.8 +/- 4.1) in 46 women with a normal laparoscopic examination. Higher mean CA-125 values also were observed in acute pelvic inflammatory disease, unexplained fertility, and pregnancy and during menstruation. The mean CA-125 value in women with treated endometriosis and a negative second-look laparoscopy was significantly lower than in women with untreated endometriosis. With the use of the 95% upper limit of 16 U/ml, the test had a sensitivity of 53% and specificity of 93%. The frequencies of elevated levels in minimal, mild, moderate, and severe endometriosis were 27%, 68%, 73%, and 100%, respectively. Changes in the CA-125 levels correlated with the clinical course of endometriosis in 37 of 44 (84%) women (P less than 0.001). The determination of CA-125 levels may assist in the evaluation and treatment of women with endometriosis.

摘要

CA - 125是一种细胞表面抗原,通过放射免疫分析法对414名女性的血清进行检测,以确定其在子宫内膜异位症诊断和管理中的潜在用途。患有轻微、轻度、中度和重度子宫内膜异位症的女性,其平均水平(±标准差)分别为13.6±6.8、22.8±15.5、27±17和50±28 U/ml,显著高于46名腹腔镜检查正常女性的平均水平(7.8±4.1)。在急性盆腔炎、不明原因的不孕症、妊娠及月经期间也观察到较高的CA - 125平均水平。接受过治疗且二次腹腔镜检查结果为阴性的子宫内膜异位症女性的CA - 125平均水平显著低于未接受治疗的女性。以16 U/ml的95%上限值为标准,该检测的灵敏度为53%,特异性为93%。轻微、轻度、中度和重度子宫内膜异位症中CA - 125水平升高的频率分别为27%、68%、73%和100%。44名女性中有37名(84%)的CA - 125水平变化与子宫内膜异位症的临床病程相关(P<0.001)。CA - 125水平的测定可能有助于对子宫内膜异位症女性进行评估和治疗。

相似文献

1
The use of CA-125 in the diagnosis and management of endometriosis.CA-125在子宫内膜异位症诊断和管理中的应用。
Fertil Steril. 1986 Nov;46(5):790-5. doi: 10.1016/s0015-0282(16)49812-2.
2
Serum CA 125 measurements in the diagnosis of endometriosis recurrence.血清CA 125检测在子宫内膜异位症复发诊断中的应用
Obstet Gynecol. 1988 Jul;72(1):19-22.
3
Placebo-controlled study on serum concentrations of CA-125 before and after treatment of endometriosis with danazol or high-dose medroxyprogesterone acetate alone or after surgery.一项安慰剂对照研究,观察单用达那唑或大剂量醋酸甲羟孕酮治疗子宫内膜异位症前后以及手术后血清CA - 125浓度的变化。
Fertil Steril. 1988 Jan;49(1):37-41. doi: 10.1016/s0015-0282(16)59644-7.
4
CA 125 antigen is an effective diagnostic for external endometriosis.CA 125抗原是诊断外在性子宫内膜异位症的一种有效方法。
Gynecol Obstet Invest. 1987;23(4):257-60. doi: 10.1159/000298869.
5
Serum CA-125 in women with endometriosis and chronic pelvic pain.患有子宫内膜异位症和慢性盆腔疼痛的女性的血清CA - 125
Fertil Steril. 1989 Jan;51(1):68-70. doi: 10.1016/s0015-0282(16)60430-2.
6
CA 125 levels in endometriosis patients before, during and after treatment with danazol or LHRH agonists.
Eur J Obstet Gynecol Reprod Biol. 1989 Sep;32(3):241-6. doi: 10.1016/0028-2243(89)90042-7.
7
Use of CA-125 in the diagnosis and management of endometriosis: influence of treatment with danazol.
Int J Fertil Menopausal Stud. 1994 Mar-Apr;39(2):100-4.
8
Serum CA-125 levels in women with endometriosis.患有子宫内膜异位症女性的血清CA - 125水平。
Aust N Z J Obstet Gynaecol. 1989 Nov;29(4):416-20. doi: 10.1111/j.1479-828x.1989.tb01779.x.
9
Serum CA-125 antigen levels increase during menses.
Am J Obstet Gynecol. 1987 Jan;156(1):75-6. doi: 10.1016/0002-9378(87)90207-9.
10
[Usefulness of measurement of serum CA125 levels in diagnosing and treating endometriosis].[血清CA125水平测定在子宫内膜异位症诊断与治疗中的应用价值]
Nihon Sanka Fujinka Gakkai Zasshi. 1987 Jul;39(7):1054-60.

引用本文的文献

1
Assessment of the prognostic value of CA125 for miscarriage risk in patients with threatened abortion: A systematic review and meta-analysis.评估CA125对先兆流产患者流产风险的预后价值:一项系统评价和荟萃分析。
PLoS One. 2025 Jun 24;20(6):e0326384. doi: 10.1371/journal.pone.0326384. eCollection 2025.
2
Comprehensive Management of Bowel Endometriosis: Surgical Techniques, Outcomes, and Best Practices.肠道子宫内膜异位症的综合管理:手术技术、结果及最佳实践
J Clin Med. 2025 Feb 3;14(3):977. doi: 10.3390/jcm14030977.
3
Single-Cell RNA Sequencing of PBMCs Identified Junction Plakoglobin (JUP) as Stratification Biomarker for Endometriosis.
外周血单核细胞的单细胞RNA测序确定桥粒斑珠蛋白(JUP)为子宫内膜异位症的分层生物标志物。
Int J Mol Sci. 2024 Dec 5;25(23):13071. doi: 10.3390/ijms252313071.
4
The Search for Biomarkers in Endometriosis: a Long and Windy Road.子宫内膜异位症生物标志物的研究:漫漫长路。
Reprod Sci. 2022 Jun;29(6):1667-1673. doi: 10.1007/s43032-021-00668-2. Epub 2021 Jun 22.
5
Serum miR-451a Levels Are Significantly Elevated in Women With Endometriosis and Recapitulated in Baboons ( Papio anubis) With Experimentally-Induced Disease.血清miR-451a水平在子宫内膜异位症女性中显著升高,并在实验性诱导疾病的狒狒(埃及狒狒)中重现。
Reprod Sci. 2017 Aug;24(8):1195-1202. doi: 10.1177/1933719116681519. Epub 2016 Dec 5.
6
Blood biomarkers for the non-invasive diagnosis of endometriosis.用于子宫内膜异位症无创诊断的血液生物标志物。
Cochrane Database Syst Rev. 2016 May 1;2016(5):CD012179. doi: 10.1002/14651858.CD012179.
7
Circulating Micro-RNAs as Diagnostic Biomarkers for Endometriosis: Privation and Promise.循环微RNA作为子宫内膜异位症的诊断生物标志物:匮乏与前景
J Minim Invasive Gynecol. 2015 Jul-Aug;22(5):719-26. doi: 10.1016/j.jmig.2015.02.021. Epub 2015 Mar 7.
8
Elevated serum cancer antigen 125 levels in advanced abdominal tuberculosis.晚期腹部结核患者血清癌胚抗原125水平升高。
Med Oncol. 2001;18(4):289-91. doi: 10.1385/MO:18:4:289.
9
Serum and tissue measurements of CA72-4 in patients with endometrial carcinoma.子宫内膜癌患者血清及组织中CA72-4的测定
J Clin Pathol. 1996 Dec;49(12):967-70. doi: 10.1136/jcp.49.12.967.
10
Characterisation and clinical usefulness of CA130 antigen recognised by monoclonal antibodies, 130-22 and 145-9, in ovarian cancers.单克隆抗体130 - 22和145 - 9识别的CA130抗原在卵巢癌中的特性及临床应用价值
Br J Cancer. 1993 Feb;67(2):237-43. doi: 10.1038/bjc.1993.46.